drugset / Trial / NCT00166036

Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells

NCT00166036

Phase 2 Completed 36 enrolled Emory University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Thirty-six subjects with hyperlipidemia and metabolic syndrome and/or diabetes were randomized in a double-blind manner to either pravastatin 80 mg or atorvastatin 10 mg daily. Oxidative stress (dROMs assay that measures lipid hydroperoxides, plasma thiobarbituric acid reactive substances \[TBARS\], and aminothiol levels) and brachial artery flow-mediated dilation (FMD) were measured at baseline and after 12 weeks of statin therapy.

Timeline

Start
2004-09
Primary completion
2008-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral
Subject Pravastatin Small molecule 80 mg Oral